Documents to download

Electronic Health Records

Electronic health records contain information about patients’ medical histories, health, care preferences and lifestyles (such as diet and exercise). It is intended that they will eventually be accessible to primary, secondary and social care providers, as well as to patients themselves. The NHS currently holds patient information in a variety of settings, both in paper form and electronically. Some health records are already stored electronically by GPs, hospitals, mental health providers and in some community care settings, but in a variety of formats which cannot always be easily shared. NHS England intends to connect electronic health records across primary, secondary and social care by 2020.

Health Secretary outlines vision for use of technology across NHS, September 2015

This system would allow people to monitor their own health and it is proposed that it will improve patient safety and health outcomes. Electronic record keeping would also aid the collection of health data for research, and inform the commissioning of health and care.

However, there are a number of challenges which are discussed in detail in the briefing:

  • managing the interoperability of IT different systems
  • implementing the systems in health settings and training staff
  • opening up the records systems so that patients can access them
  • consequences for the doctor-patient relationship
  • data security, privacy and secondary uses of patient data

Documents to download

Related posts

  • COVID-19 vaccines and virus transmission

    COVID-19 vaccines have been deployed in the UK since December 2020. This article examines the impact of COVID-19 vaccines on transmission of the virus. It also considers the potential implications of vaccine-induced protection for easing lockdown restrictions and debate about potential introduction of immunity certification or a vaccine passport scheme.

    COVID-19 vaccines and virus transmission
  • Changing the UK COVID-19 vaccine dosing schedule

    On December 31, 2020 the four UK Chief Medical Officers (CMOs) published a statement announcing changes to the dosing schedule for the second dose of the Pfizer/BioNTech and University of Oxford/AstraZeneca vaccines. It stated that the interval between the first and second dose should be extended from 3–4 weeks to up to 12 weeks. This rapid response examines the evidence behind this decision.

    Changing the UK COVID-19 vaccine dosing schedule